Financial News

Commentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug prices

Flovent was pulled from shelves, but don't blame its maker: GSK chose to switch to a lower-priced generic. The pharmacy benefit managers made more money covering the more expensive version — and that's why they pulled it from the shelves, writes two experts.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback